Onex Canada Asset Management Inc. Acquires 130,676 Shares of Sotera Health Company $SHC

Onex Canada Asset Management Inc. increased its holdings in Sotera Health Company (NASDAQ:SHC) by 31.6% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 544,771 shares of the company’s stock after purchasing an additional 130,676 shares during the quarter. Sotera Health accounts for 1.1% of Onex Canada Asset Management Inc.’s investment portfolio, making the stock its 27th biggest position. Onex Canada Asset Management Inc.’s holdings in Sotera Health were worth $8,569,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. Two Seas Capital LP increased its holdings in shares of Sotera Health by 21.1% during the second quarter. Two Seas Capital LP now owns 4,020,867 shares of the company’s stock valued at $44,712,000 after acquiring an additional 699,731 shares in the last quarter. Voss Capital LP raised its position in shares of Sotera Health by 50.0% in the 2nd quarter. Voss Capital LP now owns 750,000 shares of the company’s stock worth $8,340,000 after purchasing an additional 250,000 shares during the last quarter. CenterBook Partners LP bought a new position in Sotera Health in the 3rd quarter worth about $1,228,000. Vanguard Group Inc. boosted its stake in Sotera Health by 10.5% in the 3rd quarter. Vanguard Group Inc. now owns 16,471,792 shares of the company’s stock worth $259,101,000 after purchasing an additional 1,561,282 shares in the last quarter. Finally, Ontario Teachers Pension Plan Board purchased a new stake in Sotera Health during the 2nd quarter valued at about $1,179,000. 91.03% of the stock is owned by institutional investors.

Analyst Ratings Changes

SHC has been the subject of several analyst reports. William Blair started coverage on shares of Sotera Health in a research report on Thursday, December 18th. They set an “outperform” rating for the company. Zacks Research cut Sotera Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Citigroup increased their target price on Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, February 24th. Royal Bank Of Canada started coverage on Sotera Health in a report on Thursday, January 8th. They issued an “outperform” rating and a $24.00 target price for the company. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Sotera Health in a research note on Monday, December 29th. Eight research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Sotera Health presently has an average rating of “Moderate Buy” and a consensus target price of $20.43.

Sotera Health Trading Up 0.7%

Shares of SHC stock opened at $13.41 on Friday. The company has a debt-to-equity ratio of 3.66, a current ratio of 2.46 and a quick ratio of 2.24. The company has a market cap of $3.81 billion, a price-to-earnings ratio of 49.67 and a beta of 1.84. Sotera Health Company has a 1 year low of $9.53 and a 1 year high of $19.85. The firm has a fifty day moving average price of $17.35 and a 200-day moving average price of $16.75.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Tuesday, February 24th. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.02. The company had revenue of $303.44 million for the quarter, compared to analysts’ expectations of $300.68 million. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.Sotera Health’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the firm earned $0.21 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. As a group, equities analysts predict that Sotera Health Company will post 0.61 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $15.27, for a total value of $152,700,000.00. Following the transaction, the director owned 12,735,301 shares of the company’s stock, valued at $194,468,046.27. This trade represents a 43.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 47.55% of the stock is currently owned by insiders.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.